BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare
Director Nancy J Hutson sold $103K of BioCryst Pharmaceuticals, Inc.
Sold$103,443
$8.04Price
12,866Shares
−14%Stake
What BCRX did after the filing
- The stock from Thu, Jun 15 close, $7.98
- −7.4%
- S&P 500, same days
- +3.8%
Measured over 30 trading days, to the Jul 31 close.
Traded Wed, Jun 14. Filed Thu, Jun 15, 12:33 PM ET, during the session. Returns use the Jun 15 close and the Jul 31 close. Not investment advice.